Apazone (azapropazone) is not approved for marketing in the United States by the U.S. Food and Drug Administration. Relatively small amounts of the drug are excreted into breastmilk; however, the toxicity of the drug limits its usefulness in nursing mothers.[1] An alternate drug is preferred, especially while nursing a newborn or preterm infant.
阿扎丙宗（azapropazone）未获美国食品药品监督管理局批准在美国上市。相对少量的该药物会排泄到母乳中；然而，药物的毒性限制了其在哺乳期母亲中的应用。[1] 首选替代药物，尤其是在哺乳新生儿或早产儿期间。
